2018
DOI: 10.1096/fasebj.2018.32.1_supplement.835.3
|View full text |Cite
|
Sign up to set email alerts
|

Searching for a new cancer drug: Kentucky Hemp‐induced modulation of ovarian cancer cell proliferation and total cell death

Abstract: Marijuana (cannabis sativa), a schedule 1 drug has been recently approved by some of states in the US for its therapeutic benefit. Although few reports discuss about its anti‐cancer potential, currently it has been used mainly for epilepsy and to alleviate pain associated with many diseases. However, due to marijuana's addictive potential there are restrictions for its use. Hemp, which belongs to the same genus and species as marijuana shows similar therapeutic benefits with much less addictive potential due t… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles